<DOC>
	<DOCNO>NCT00153127</DOCNO>
	<brief_summary>The purpose study assess treatment response compare newly FDA-approved PEG laxative versus placebo .</brief_summary>
	<brief_title>Comparison PolyethyleneGlycol Placebo Relief Constipation From Constipating Medications</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>Adult male female ambulatory outpatient age 19 old . Patients meet ROME II Criteria Patients meet ROME IBS criterion Use constipate medication ( &gt; = 3 % PDR ) If female childbearing potential , patient must surgically sterilize use oral contraceptive , depot contraceptive , intrauterine device , testify monogamous vasectomized partner , practice abstinence continue duration study Written inform consent . Known suspected obstruction , gastric retention , ileus , perforation , fecal impaction inflammatory bowel disease . Prior small bowel colonic resection colostomy . Weight &lt; 80 lb . Unwilling unable undergo colon diagnostic examination end study perform within 5 year informed consent date advise clinically accepted indication . Positive stool hemoccult . Significant cardiac , renal hepatic insufficiency . Pregnant expect become pregnant within 120 day study enrollment . Lactating breast feeding . Subjects opinion investigator would unable comply adequately study plan . Use investigational drug last 30 day . Patients know allergy PEG PEG medication PEG sulfatefree electrolyte lavage solution</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>